Furthermore, a number of studies revealed a correlation between CD44 and CD133 expression: for example, CD44 and CD133 could be used as biomarkers for hepatic metastases of CRC, due their mRNA co-expression in liver metastases[30]. The gene discussed is CD44; the disease is colorectal carcinoma.